Clinical trials
Schizophrenia trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
109 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 6 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 8 |
| 2008 | 10 |
| 2009 | 10 |
| 2010 | 10 |
| 2011 | 10 |
| 2012 | 7 |
| 2013 | 10 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 6 |
| 2019 | 6 |
| 2020 | 3 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 96 |
| Terminated | 11 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 17 |
| Sumitomo Pharma America, Inc. | 9 |
| Hoffmann-La Roche | 8 |
| Eli Lilly and Company | 7 |
| AstraZeneca | 6 |
| Denovo Biopharma LLC | 6 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 6 |
| Alkermes, Inc. | 5 |
| Janssen Research & Development, LLC | 5 |
| ACADIA Pharmaceuticals Inc. | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 109 |
| Psychotic Disorders | 11 |
| Bipolar Disorder | 5 |
| Cognition Disorders | 3 |
| Mental Disorders | 3 |
| Mania | 2 |
| Recurrence | 2 |
| Anxiety Disorders | 1 |
| Autistic Disorder | 1 |
| Catatonia | 1 |
Trials
Showing 26 to 50 of 109. Each trial links to its page on Pharma Observatory.
9 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.